Daily Archives: April 24, 2018 | LinksMedicus Free Medical News & Perspectives

“Antifibrinolytics appear effective tor treating for heavy menstrual bleeding, without substantially increasing the rate of adverse events” (via @CochraneLibrary see Tweet)

Expert Analysis: Major Dyslipidemia Guidelines and Their Discrepancies

24 Apr, 2018 | 17:58h | UTC

Major Dyslipidemia Guidelines and Their Discrepancies: A Need for Consensus – American College of Cardiology (free)

FDA Approves Rapid Diagnostic Test for Candida Auris

24 Apr, 2018 | 17:57h | UTC

FDA approves rapid diagnostic test for Candida auris – CIDRAP (free)

FDA News Release: FDA authorizes new use of test, first to identify the emerging pathogen Candida auris (free)

Related: Tracking Candida auris – CDC (free)

Review: The Vasculature in Prediabetes

24 Apr, 2018 | 17:59h | UTC

The Vasculature in Prediabetes – Circulation Research (free for a limited period) (via @Abraham_RMI)

Tue, April 24 – 10 Stories of The Day!

24 Apr, 2018 | 01:43h | UTC

1 – World Immunization Week, 24-30 April 2018 – World Health Organization (free resources)

2 – The vaccine dilemma: how experts weigh benefits for many against risks for a few – STAT (free)

3 – Why do we need vaccines? – Welcome Trust (free) (via @greg_folkers)

4 – Exercise after a heart attack — it could save your life, research suggests – European Society of Cardiology, via ScienceDaily (free)

Other commentaries: Regular exercise after heart attack might halve risk of death over next few years – OnMedica (free) AND It’s not too late: Exercise after heart attack cuts mortality risk – Cardiovascular Business (free) AND Remaining Active After MI May Help Stave Off Mortality – TCTMD (free)

“Becoming more physically active after a myocardial infarction halves the risk of dying within 4 years, study finds”

5 – Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials – European Heart Journal (free)

“Compared with triple antithrombotic therapy, dual antithrombotic therapy shows a reduction in major or minor bleeding by 47% with comparable outcomes of major adverse cardiac events”.

6 – Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis – Neurology (free)

See also: Related Physician Tools and Materials (free clinician summary, slides and more)

Commentaries: New guideline: Start taking MS drugs early on – American Academy of Neurology, via EurekAlert (free) AND New MS Guideline Addresses Starting, Switching, and Stopping Disease-modifying Therapy – MD Magazine (free) AND Start MS Drugs Early, New Guideline Says – MedPage Today (free registration required)

7 – Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV – AIDSInfo (free)

8 – Richard Lehman’s journal review, 23 April 2018 – The BMJ Opinion (free)

Richard Lehman reviews the latest research in the top medical journals.

9 – State of the Art Review: Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications – The BMJ (free for a limited period)

10 – Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults – Journal of the American Geriatrics Society (free)

Commentary: Commonly prescribed heartburn drug linked to Pneumonia in Older Adults – University of Exeter (free)

Source: Hospital Medicine Virtual Journal Club

Stay Updated in Your Specialty